Mesa Laboratories Inc

MLAB | Technology | NASDAQ
$71.39
-2.35 (-3.19%)

Key Metrics

Market Cap
$392.75M
P/E Ratio
-549.15
EPS
$-0.13
Beta
N/A
Dividend Yield
N/A
ROE
-0.38%
Current Ratio
0.66

Company Information

Industry
Hardware Equipment Parts

About Mesa Laboratories Inc

Mesa Laboratories Inc develops manufactures and sells life sciences tools and quality control products and services in the United States Europe the Asia Pacific and internationally The companys Sterilization and Disinfection Control segment manufactures and sells biological cleaning and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital dental medical device and pharmaceutical industries This segment also provides testing and laboratory services primarily to the dental industry Its Biopharmaceutical Development segment develops manufactures and sells automated systems for protein analysis immunoassays and peptide synthesis solutions This segments solutions include protein analysis comprising analysis equipment CDs kits and buffers and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies biomaterials cosmetics and general research The companys Calibration Solutions segment designs manufactures and markets quality control and calibration products to measure or calibrate temperature pressure pH humidity and other such parameters used for health and safety purposes in the hospital medical device manufacturing pharmaceutical manufacturing and various laboratory and healthcare environments This segments products include continuous monitoring systems dialysate meters and consumables data loggers gas flow calibration and air sampling equipment and torque testing systems Its Clinical Genomics segment develops manufactures and sells genetic analysis tools that include MassARRAY system and consumables including chips panels and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas such as newborn screenings pharmacogenetics and oncology The company was incorporated in 1982 and is headquartered in Lakewood Colorado

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-08-05 $2.32 $2.46 -5.7%
2025-05-28 $2.23 $2.75 -18.9%
2025-02-04 $2.67 $1.41 +89.4%
2024-11-07 $2.45 $2.48 -1.2%

Financial Ratios (TTM)

Gross Margin
60.29%
Operating Margin
5.70%
Net Margin
-0.26%
ROA
-0.14%
Price to Book
2.34
Price to Sales
1.67